PARP9
(Poly (ADP-Ribose) Polymerase Family, Member 9 (PARP9))
Protein Region
N-Term
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-PARP9 antibody (Catalog #: ARP33776_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
PARP9
(Poly (ADP-Ribose) Polymerase Family, Member 9 (PARP9))
Synonyme
RGD1307534 Peptide, ARTD9 Peptide, BAL Peptide, BAL1 Peptide, MGC:7868 Peptide, AW214463 Peptide, BC003281 Peptide, Bagl Peptide, Bal Peptide, PARP-9 Peptide, poly (ADP-ribose) polymerase family, member 9 Peptide, poly(ADP-ribose) polymerase family member 9 Peptide, si:ch211-219a4.6 Peptide, Parp9 Peptide, PARP9 Peptide, si:ch211-219a4.6 Peptide
Hintergrund
PARP9 contains 2 Macro domains and 1 PARP catalytic domain. PARP9 is overexpressed at significantly higher levels in fatal high-risk diffuse large B-cell lymphomas (DLB-CL) compared to cured low-risk tumors. Overexpression of PARP9 in B-cell lymphoma transfectants may promote malignant B-cell migration. The function of PARP9 remains unknown.
Alias Symbols: BAL, BAL1, DKFZp666B0810, DKFZp686M15238, FLJ26637, FLJ41418, MGC:7868